Purple Book reference family · 351(a) biologic
Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) (Atgam)
Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) is an FDA-licensed reference biologic from Pharmacia & Upjohn Company LLC.
351(a) biologicBLA 103676 Pharmacia & Upjohn Company LLC
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
1996
Reference product
Originator biologic
351(a)BLA 103676
Atgam Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine)
Pharmacia & Upjohn Company LLC
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) product.
30 yr 1 mo ago
Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine): frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine).
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
